SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-055641
Filing Date
2010-10-27
Accepted
2010-10-27 09:11:37
Documents
7
Period of Report
2010-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v199983_8k.htm 8-K 66327
2 v199983_ex4-1.htm EX-4.1 809052
3 v199983_ex10-1.htm EX-10.1 65944
4 v199983_ex10-2.htm EX-10.2 56788
5 v199983_ex10-3.htm EX-10.3 80219
6 v199983_ex99-1.htm EX-99.1 18117
7 GRAPHIC logo.jpg GRAPHIC 2750
  Complete submission text file 0001144204-10-055641.txt   1102220
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 101143671
SIC: 2836 Biological Products, (No Diagnostic Substances)